Agglo Corp. , Ltd.

Agglo Corp., Ltd. specializes in children’s sunglasses. These products are designed to shield young eyes from harmful ultraviolet (UV) radiation while ensuring clear and comfortable vision during outdoor activities. The focus on children’s eye protection aligns with the company’s mission to provide safe and functional eyewear for a specific demographic.

Agglo Corp., Ltd. is headquartered in the United States. Since the company operates within the U.S. market, its devices are subject to FDA regulations. The location ensures compliance with domestic regulatory requirements, including classification and listing processes specific to the FDA’s framework.

Agglo Corp., Ltd.’s children’s sunglasses are classified as Class I medical devices by the FDA. This classification is typically assigned to low-risk products, such as general-purpose eyewear designed to protect against UV radiation. Class I devices often require general controls (like good manufacturing practices) rather than stringent pre-market submissions, reflecting their minimal risk profile.

Agglo Corp., Ltd. lists its children’s sunglasses through the FDA’s 510(k) pathway. This pathway is used for devices that are substantially equivalent to a legally marketed predicate device. Since sunglasses fall under a well-established category with existing benchmarks, the 510(k) process allows the company to demonstrate compliance by comparing its product to a previously authorized device rather than undergoing a de novo classification.